Greece is currently observing a research & development by business enterprise, pharmaceutical industry in constant ppp $ of 149.43 million, marking a decrease of 8.48 million (-5.4%) compared to 2020.
Research & development by business enterprise, pharmaceutical industry in constant PPP $ in Greece
No matching regions
Similar regions to Greece
Business R&D pharmaceutical in constant PPP $
More indicators for Greece
Government R&D in security as % of government support
1.41%
-0.09%
(2021)
Higher-education-finacing R&D financed by general university in local currency
3,734.72M
+65.42M
(2021)
R&D financed by rest of the world in local currency
3,806.09M
+208.69M
(2021)
Government R&D financed by rest of the world in local currency
920.23M
+200.43M
(2021)
Business R&D financed by rest of the world in local currency
1,625.81M
+254.61M
(2021)
Non-profit R&D growth rate
5.12%
+1.26%
(2022)
Greece Business R&D pharmaceutical in constant PPP $ between 2011 and 2021
| Period | Business R&D pharmaceutical in constant PPP $ | Change |
|---|---|---|
| 2021 | 149.43M | -8.48M |
| 2020 | 157.91M | +33.23M |
| 2019 | 124.68M | +27.11M |
| 2018 | 97.57M | +14.11M |
| 2017 | 83.45M | +15.25M |
| 2016 | 68.21M | -1.08M |
| 2015 | 69.29M | -14.96M |
| 2014 | 84.24M | -10.17M |
| 2013 | 94.41M | +4.09M |
| 2012 | 90.32M | -4.26M |
| 2011 | 94.58M |